Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine. | BMC Pharmacol Toxicol | 2014 | 25413361 | PubTator, text mining | PubMed |
| Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models. | Arch Toxicol | 2014 | 25370008 | PubTator, text mining | PubMed |
| Drug and xenobiotic biotransformation in the blood-brain barrier: a neglected issue. | Front Cell Neurosci | 2014 | 25368552 | PubTator, text mining | PubMed |
| Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study. | Cancer Med | 2014 | 25355624 | PubTator, text mining | PubMed |
| Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci. | Mol Vis | 2014 | 25352737 | PubTator, text mining | PubMed |
| Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. | Nat Commun | 2014 | 25352340 | PubTator, text mining | PubMed |
| [Tuberculosis: relevance of isoniazid dosage in prevention of liver side effects]. | Therapie | 2014 | 25314930 | PubTator, text mining | PubMed |
| Is personalized medicine achievable in obstetrics? | Semin Perinatol | 2014 | 25282474 | PubTator, text mining | PubMed |
| Cancer-promoting and Inhibiting Effects of Dietary Compounds: Role of the Aryl Hydrocarbon Receptor (AhR). | Biochem Pharmacol (Los Angel) | 2014 | 25258701 | PubTator, text mining | PubMed |
| Screening of susceptibility genes and multi-gene risk analysis in gastric cancer. | Med Oncol | 2014 | 25245011 | PubTator, text mining | PubMed |
| Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole. | Biochem Pharmacol | 2014 | 25241292 | PubTator, text mining | PubMed |
| Environmental changes, microbiota, and allergic diseases. | Allergy Asthma Immunol Res | 2014 | 25228995 | PubTator, text mining | PubMed |
| Effects of dosage, comorbidities, and food on isoniazid pharmacokinetics in Peruvian tuberculosis patients. | Antimicrob Agents Chemother | 2014 | 25224007 | PubTator, text mining | PubMed |
| Persistent pharmacokinetic challenges to pediatric drug development. | Front Genet | 2014 | 25221567 | PubTator, text mining | PubMed |
| Differences in EBA in the first two days of standard anti-tuberculosis treatment in different geographic regions. | Int J Tuberc Lung Dis | 2014 | 25199023 | PubTator, text mining | PubMed |
| Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia. | PLoS One | 2014 | 25184238 | PubTator, text mining | PubMed |
| Improved drug therapy: triangulating phenomics with genomics and metabolomics. | Hum Genomics | 2014 | 25181945 | PubTator, text mining | PubMed |
| Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma. | Cancer Causes Control | 2014 | 25178586 | PubTator, text mining | PubMed |
| Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population. | Mol Biol Rep | 2014 | 25163630 | PubTator, text mining | PubMed |
| Genetic polymorphisms affect efficacy and adverse drug reactions of DMARDs in rheumatoid arthritis. | Pharmacogenet Genomics | 2014 | 25144752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=84